← All trials
NCT04435249
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2020
- Primary completion
- Mar 31, 2022
- Completion date
- Jul 31, 2025
- First posted
- Jun 17, 2020
- Last posted
- Jun 17, 2020
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cell Therapy CatapultLead sponsor
- University of LondonCollaborator
- Papworth HospitalCollaborator
- Videregen TherapeuticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.